Sopharma
1933
FOUNDED
PUBLIC
STATUS
5K-10K
EMPLOYEES
3JR
STOCK SYMBOL
21
INVESTMENTS
$1.85
SHARE PRICE
(As of Friday Closing)
Description
Sopharma AD-Sofia is a Bulgaria based producer, exporter, and distributor of pharmaceutical products. It is engaged in the production of pharmaceutical products including medicines, primarily generics, herbal-based substances and food supplements. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements and cosmetics. The company operates in Bulgaria and internationally.
Primary Industry
Pharmaceuticals
Stock Exchange
XBUL
Primary Office
- 16 Iliensko shose Street
- Sofia, 1220
- Bulgaria
+359 02 000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Sopharma’s full profile, request a free trial.
Sopharma Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $1.82 - $2.17 | $233M | $1.90 | $0.08 | 14.8K | 126M |
Sopharma Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 453,697 | 438,697 | 481,009 | 336,088 |
| Revenue | 714,301 | 708,679 | 585,105 | 493,121 |
| EBITDA | 53,190 | 43,501 | 48,847 | 52,988 |
| Net Income | 20,208 | 17,034 | 23,009 | 28,470 |
| Total Assets | 640,868 | 588,981 | 599,668 | 464,896 |
| Total Debt | 225,265 | 176,320 | 160,438 | 113,586 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Sopharma Investments & Acquisitions (21)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 19-Sep-2017 | 000000000 00000000 | Pharmaceuticals | ||
| 000000 | 09-Aug-2017 | 000000000000000000 | Pharmaceuticals | ||
| 00000000 | 21-Jul-2017 | 000000000000000000 | Drug Discovery | ||
| 000 000000 0000000 | 18-Apr-2017 | 000000000000000000 | Distributors (Healthcare) | ||
| Unipharm | 01-Dec-2016 | Merger/Acquisition | Pharmaceuticals |
Sopharma Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 0 000000 | 31-Mar-2008 | 000000000000000000 | Completed |
|
|
| Sopharma Zdrovit | 27-Sep-2007 | Joint Venture | Completed |
|
Sopharma Subsidiaries (6)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Aromania | Drug Discovery | Sofia, Bulgaria | 2015 |
| 00000000 | Pharmaceuticals | Sofia, Bulgaria | 0000 |
| 0000 | Acquirer | Riga, Latvia | 0000 |
| 000000 | Pharmaceuticals | Sofia, Bulgaria | 0000 |
| 00000000 | Pharmaceuticals | Uman, Ukraine | 0000 |
Sopharma Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Ognian Donev Ph.D | Chief Executive Officer, Chairman of the Board of Directors and Executive Director | ||
| Boris Borisov | Chief Financial Officer |
Sopharma Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 000000 00000 00.0 | Sopharma | Chief Executive Officer, Chairman of the Board of Directors and Executive Director | 000 0000 |